As an impact of busy, modern lifestyle, the consumption of healthy food among humans has been limited, and at times, individuals disturb the delicate balance of the body’s intestinal flora, which can cause occasional gastrointestinal discomfort, and infection in other body parts. Therefore, a healthy balance of intestinal flora and infection control can be supported through the consumption of food or food supplement products that contain friendly live bacteria cultures, commonly referred to as 'probiotics'. Probiotics are live micro-organisms, when administered in adequate amount confer a health benefit on the host”, is the standard definition provided by the Food and Agriculture Association (FAO) of the United Nations. These friendly and live bacteria, when administered to and/or consumed by humans in the non-food form, are referred to as 'probiotic supplements’, which are generally available either in the form of tablets, capsules, powder, liquid, chewables, and others.
The global revenue generated from Probiotics market is estimated to be valued at roughly US$ 6,762.2 Mn by the end of 2018 and is expected to increase at a CAGR of 8.3% over the forecast period. Global Probiotics market are expected to be valued at approximately US$ 12,753.4 Mn by the end of 2026.
Consumption of antibiotics per capita is increasing on the backdrop of the increase in healthcare expenditure and out of pocket pharmaceutical spending. Low and middle income countries are growing in terms of per capita disposable income, and this factor is boosting antibiotic consumption in these countries. Furthermore, favorable policies to push antibiotics in these countries have amplified the usage of antibiotics in some of these countries. Excessive usage of antibiotics by an individual results in imbalance of microbiota, and also lowers the bacterial diversity as well as overall bacterial count in the gut.
Harmful effects of excess antibiotic consumption has been reported, necessitating the additional supplementation of friendly bacteria into the body. Some of these bacteria have also developed antibiotic resistant characteristics, and do not respond to the consumed antibiotics. It is thus important to replenish such bacteria in the body, thus nucleating targeted bacterial strain consumption. A larger chunk of such population relying on antibiotics has absorbed the importance of probiotic supplements, and have started consuming them. The consumption of antibiotics has shown a significant rise in BRICS countries in the last decade; some antibiotics are available over the counter in these countries. Needles to says, probiotic supplement manufacturers have also adopted a targeted approach in these countries, and have invested in marketing efforts. These factors collectively are expected to support the overall demand for probiotic supplements across the globe.
By form, the Probiotics market is segmented into dry and liquid. The dry segment is further sub-segmented as tablets/ caplets, capsules, powder/ granules and chewables. The dry segment is likely to be the most attractive segment in the forecast period owing to the availability of larger product variants coupled increasing product offerings in powder/granule format.
On the basis of packaging type, the Probiotics market can be segmented into blisters, bottles, containers, sachets, stick packs, droppers and others. Among all these segment the containers segment is estimated to account for a significant revenue share of 24.7% in 2018 and is expected to register significant growth rate during the forecast period. However the bottle segment is expected to register comparatively largest CAGR growth of 8.7% during the forecast period.
Furthermore, on the basis of distribution channel, the Probiotics market is segmented into hypermarkets/ supermarkets, pharmacies/ drugstores, specialty stores and online sales.
On the basis of region, the market in North America and Europe is expected to dominate in terms of value share over the forecast period followed by Asia Pacific. Asia pacific is expected to become a prominent market by the end of the forecast period with a significant CAGR attributed to increase in product penetration and rising awareness through various promotional activities.
Some of the major companies operating in the global Probiotics market are Chr. Hansen Holding A/S, BioGaia AB, Probi AB, Nestlé S.A., DowDuPont Inc., The Procter & Gamble Company, Probiotics International Limited, Lallemand Inc. Pfizer Inc., PharmaCare Laboratories, Dr. Willmar Schwabe Group, SymbioPharm GmbH and others.
Increasing Demand for Healthy Bacteria for Gut Health will Boost Probiotics Market
The rising popularity of customized medication is likely to aid in expansion of the global probiotics market. Utilization of anti-infection agents per capita is expanding on the scenery of the increment in medical services use and cash based drug spending. Low and center pay nations are filling as far according to capita extra cash, and this factor is boosting anti-toxin utilization in these nations. Besides, good arrangements to push anti-toxins in these nations have enhanced the use of anti-infection agents in a portion of these nations. The demand for healthy bacteria with heavy investments for promotional activity will further aid in expansion of the global probiotics market in the future years.
Anti-microbials are progressively utilized in different clinical diagnosis around the globe. Furthermore, discretionary cashflow is on the ascent in arising nations. Developing mindfulness with respect to results of anti-infection agents is relied upon to help the worldwide probiotics market. Probiotics, for example, lactobacillus acidophilus are likely to bring down cholesterol, and furthermore assist with loose bowels and bacterial vaginitis.
The contradictory effects of consuming antibiotics have been accounted for, further propelling the addition of bacteria that benefits the body. A portion of these microscopic organisms have additionally evolved anti-microbial safe attributes, and don't react to the devoured anti-infection agents. It is accordingly important to recharge such microorganisms in the body, along these lines nucleating focused on bacterial strain utilization. A bigger piece of such populace depending on anti-toxins has assimilated the significance of probiotic supplements, and has begun burning-through them. The utilization of anti-microbial has indicated a huge ascent in BRICS nations in the most recent decade; a few anti-infection agents are accessible over the counter in these nations. Needles to says, probiotic supplement makers have additionally embraced a focused on methodology in these nations, and have put resources into promoting endeavors. These variables all in all are required to help the general interest for probiotic supplements across the globe.
The global probiotics Market is segmented as below:
Segments |
|
Probiotics Market is expected to reach US$12,753.4 Mn By 2026
Probiotics Market is estimated to rise at a CAGR of 8.3% during forecast period
Demand for healthy bacteria for Gut Health will drive the Probiotics Market
Asia Pacific is more attractive for vendors in the Probiotics Market
Key players of Probiotics Market are Chr. Hansen Holding A/S, BioGaia AB, Probi AB, Nestlé S.A., DowDuPont Inc., The Procter & Gamble Company, Probiotics International Limited, Lallemand Inc. Pfizer Inc., PharmaCare Laboratories, Dr. Willmar Schwabe Group, SymbioPharm GmbH and others
1. Global Probiotic Market - Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. Global Probiotic Market Analysis Scenario
3.1. Global Pharmaceutical Industry Overview
3.2. Global Probiotics Market Outlook
3.3. Global Packaging Industry Outlook
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
4.5. Trends
4.6. Key Regulations
4.7. Value Chain Analysis
4.8. Forecast Factors – Relevance and Impact
5. Global Probiotic Market Analysis
5.1. Market Size and Forecast
6. Global Probiotic Market Analysis and Forecast, By Region
6.1. Introduction
6.1.1. Y-o-Y Growth Comparison By Region
6.1.2. Basis Point Share (BPS) Analysis By Region
6.2. Market Size (US$ Mn) and Forecast (2018-2026), By Region
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. Asia Pacific
6.2.5. Middle East & Africa
6.3. Market Attractiveness Analysis By Region
7. Global Probiotic Market Analysis and Forecast, By Form
7.1. Introduction
7.1.1. Y-o-Y Growth Comparison By Form
7.1.2. Basis Point Share (BPS) Analysis By Form
7.2. Market Size (US$ Mn) and Forecast (2018-2026), By Form
7.2.1. Dry
7.2.1.1. Tablets/Caplets
7.2.1.2. Capsules
7.2.1.3. Powder/Granules
7.2.1.4. Chewables
7.2.2. Liquid
7.3. Market Attractiveness Analysis By Form
8. Global Probiotic Market Analysis and Forecast, By Packaging Type
8.1. Introduction
8.1.1. Y-o-Y Growth Comparison By Packaging Type
8.1.2. Basis Point Share (BPS) Analysis By Packaging Type
8.2. Market Size (US$ Mn) and Forecast (2018-2026), By Packaging Type
8.2.1. Blister
8.2.2. Bottles
8.2.3. Container
8.2.4. Sachets
8.2.5. Stick packs
8.2.6. Dropper
8.2.7. Others
8.3. Market Attractiveness Analysis By Packaging Type
9. Global Probiotic Market Analysis and Forecast, By Distribution Channel
9.1. Introduction
9.1.1. Y-o-Y Growth Comparison By Distribution Channel
9.1.2. Basis Point Share (BPS) Analysis By Distribution Channel
9.2. Market Size (US$ Mn) and Forecast (2018-2026), By Distribution Channel
9.2.1. Hypermarkets/Supermarkets
9.2.2. Pharmacy/Drugstores
9.2.3. Specialty Stores
9.2.4. Online Sales
9.3. Market Attractiveness Analysis By Distribution Channel
10. North America Probiotic Market Analysis and Forecast
10.1. Introduction
10.2. Market Size (US$ Mn) and Forecast (2018-2026), By Dietary Supplements Market Segments
10.2.1. By Country
10.2.1.1. U.S
10.2.1.2. Canada
10.2.2. By Form
10.2.3. By Packaging Type
10.2.4. By Distribution Channel
10.3. Market Size (US$ Mn) and Forecast (2018-2026), By Pharmaceuticals Market Segments
10.3.1. By Country
10.3.1.1. U.S
10.3.1.2. Canada
10.3.2. By Form
10.3.3. By Packaging Type
10.3.4. By Distribution Channel
10.4. Market Attractiveness Analysis By Dietary Supplements
10.4.1. By Country
10.4.2. By Form
10.4.3. By Packaging
10.4.4. By Distribution Channel
10.5. Market Attractiveness Analysis By Pharmaceuticals
10.5.1. By Country
10.5.2. By Form
10.5.3. By Packaging
10.5.4. By Distribution Channel
10.6. Drivers and Restraints: Impact Analysis
11. Latin America Probiotic Market Analysis and Forecast
11.1. Introduction
11.2. Market Size (US$ Mn) and Forecast (2018-2026), By Dietary Supplements Market Segments
11.2.1. By Country
11.2.1.1. Brazil
11.2.1.2. Mexico
11.2.1.3. Argentina
11.2.1.4. Peru
11.2.1.5. Chile
11.2.1.6. Colombia
11.2.1.7. Rest of Latin America
11.2.2. By Form
11.2.3. By Packaging Type
11.2.4. By Distribution Channel
11.3. Market Size (US$ Mn) and Forecast (2018-2026), By Pharmaceuticals Market Segments
11.3.1. By Country
11.3.1.1. Brazil
11.3.1.2. Mexico
11.3.1.3. Argentina
11.3.1.4. Peru
11.3.1.5. Chile
11.3.1.6. Colombia
11.3.1.7. Rest of Latin America
11.3.2. By Form
11.3.3. By Packaging Type
11.3.4. By Distribution Channel
11.4. Market Attractiveness Analysis By Dietary Supplements
11.4.1. By Country
11.4.2. By Form
11.4.3. By Packaging
11.4.4. By Distribution Channel
11.5. Market Attractiveness Analysis By Pharmaceuticals
11.5.1. By Country
11.5.2. By Form
11.5.3. By Packaging
11.5.4. By Distribution Channel
11.6. Drivers and Restraints: Impact Analysis
12. Europe Probiotic Market Analysis and Forecast
12.1. Introduction
12.2. Market Size (US$ Mn) and Forecast (2018-2026), By Dietary Supplements Market Segments
12.2.1. By Country
12.2.1.1. Germany
12.2.1.2. France
12.2.1.3. Italy
12.2.1.4. U.K.
12.2.1.5. Spain
12.2.1.6. Nordic
12.2.1.7. Poland
12.2.1.8. Portugal
12.2.1.9. Russia
12.2.1.10. Rest of Europe
12.2.2. By Form
12.2.3. By Packaging Type
12.2.4. By Distribution Channel
12.3. Market Size (US$ Mn) and Forecast (2018-2026), By Pharmaceuticals Market Segments
12.3.1. By Country
12.3.1.1. Germany
12.3.1.2. France
12.3.1.3. Italy
12.3.1.4. U.K.
12.3.1.5. Spain
12.3.1.6. Nordic
12.3.1.7. Poland
12.3.1.8. Portugal
12.3.1.9. Russia
12.3.1.10. Rest of Europe
12.3.2. By Form
12.3.3. By Packaging Type
12.3.4. By Distribution Channel
12.4. Market Attractiveness Analysis By Dietary Supplements
12.4.1. By Country
12.4.2. By Form
12.4.3. By Packaging
12.4.4. By Distribution Channel
12.5. Market Attractiveness Analysis By Pharmaceuticals
12.5.1. By Country
12.5.2. By Form
12.5.3. By Packaging
12.5.4. By Distribution Channel
12.6. Drivers and Restraints: Impact Analysis
13. Asia Pacific Probiotic Market Analysis and Forecast
13.1. Introduction
13.2. Market Size (US$ Mn) and Forecast (2018-2026), By Dietary Supplements Market Segments
13.2.1. By Country
13.2.1.1. India
13.2.1.2. China
13.2.1.3. Japan
13.2.1.4. Australia & New Zealand
13.2.1.5. South Korea
13.2.1.6. Rest of APAC
13.2.2. By Form
13.2.3. By Packaging Type
13.2.4. By Distribution Channel
13.3. Market Size (US$ Mn) and Forecast (2018-2026), By Pharmaceuticals Market Segments
13.3.1. By Country
13.3.1.1. India
13.3.1.2. China
13.3.1.3. Japan
13.3.1.4. Australia & New Zealand
13.3.1.5. South Korea
13.3.1.6. Rest of APAC
13.3.2. By Form
13.3.3. By Packaging Type
13.3.4. By Distribution Channel
13.4. Market Attractiveness Analysis By Dietary Supplements
13.4.1. By Country
13.4.2. By Form
13.4.3. By Packaging
13.4.4. By Distribution Channel
13.5. Market Attractiveness Analysis By Pharmaceuticals
13.5.1. By Country
13.5.2. By Form
13.5.3. By Packaging
13.5.4. By Distribution Channel
13.6. Drivers and Restraints: Impact Analysis
14. Middle East & Africa Probiotic Market Analysis and Forecast
14.1. Introduction
14.2. Market Size (US$ Mn) and Forecast (2018-2026), By Dietary Supplements Market Segments
14.2.1. By Country
14.2.1.1. GCC
14.2.1.2. Turkey
14.2.1.3. North Africa
14.2.1.4. South Africa
14.2.1.5. Rest of MEA
14.2.2. By Form
14.2.3. By Packaging Type
14.2.4. By Distribution Channel
14.3. Market Size (US$ Mn) and Forecast (2018-2026), By Pharmaceuticals Market Segments
14.3.1. By Country
14.3.1.1. GCC
14.3.1.2. Turkey
14.3.1.3. North Africa
14.3.1.4. South Africa
14.3.1.5. Rest of MEA
14.3.2. By Form
14.3.3. By Packaging Type
14.3.4. By Distribution Channel
14.4. Market Attractiveness Analysis By Dietary Supplements
14.4.1. By Country
14.4.2. By Form
14.4.3. By Packaging
14.4.4. By Distribution Channel
14.5. Market Attractiveness Analysis By Pharmaceuticals
14.5.1. By Country
14.5.2. By Form
14.5.3. By Packaging
14.5.4. By Distribution Channel
14.6. Drivers and Restraints: Impact Analysis
15. Competitive Landscape
15.1. Market Structure
15.2. Brand Analysis (Leading Brands Market Share)
15.3. Market Presence
15.4. Competition Dashboard
15.4.1. Chr. Hansen Holding A/S
15.4.1.1. Overview
15.4.1.2. Regional Presence
15.4.1.3. Segment Financials
15.4.1.4. Strategic Overview
15.4.1.5. Product Offerings
15.4.1.6. Recent Developments
15.4.1.7. SWOT Analysis
15.4.2. BioGaia AB
15.4.2.1. Overview
15.4.2.2. Regional Presence
15.4.2.3. Segment Financials
15.4.2.4. Strategic Overview
15.4.2.5. Product Offerings
15.4.2.6. Recent Developments
15.4.2.7. SWOT Analysis
15.4.3. Probi AB
15.4.3.1. Overview
15.4.3.2. Regional Presence
15.4.3.3. Segment Financials
15.4.3.4. Strategic Overview
15.4.3.5. Product Offerings
15.4.3.6. Recent Developments
15.4.3.7. SWOT Analysis
15.4.4. Nestlé S.A.
15.4.4.1. Overview
15.4.4.2. Regional Presence
15.4.4.3. Segment Financials
15.4.4.4. Strategic Overview
15.4.4.5. Product Offerings
15.4.4.6. Recent Developments
15.4.4.7. SWOT Analysis
15.4.5. DowDuPont Inc.
15.4.5.1. Overview
15.4.5.2. Regional Presence
15.4.5.3. Segment Financials
15.4.5.4. Strategic Overview
15.4.5.5. Product Offerings
15.4.5.6. Recent Developments
15.4.5.7. SWOT Analysis
15.4.6. The Procter & Gamble Company
15.4.6.1. Overview
15.4.6.2. Regional Presence
15.4.6.3. Segment Financials
15.4.6.4. Strategic Overview
15.4.6.5. Product Offerings
15.4.6.6. Recent Developments
15.4.6.7. SWOT Analysis
15.4.7. Probiotics International Limited
15.4.7.1. Overview
15.4.7.2. Regional Presence
15.4.7.3. Segment Financials
15.4.7.4. Strategic Overview
15.4.7.5. Product Offerings
15.4.7.6. Recent Developments
15.4.7.7. SWOT Analysis
15.4.8. Lallemand Inc.
15.4.8.1. Overview
15.4.8.2. Regional Presence
15.4.8.3. Segment Financials
15.4.8.4. Strategic Overview
15.4.8.5. Product Offerings
15.4.8.6. Recent Developments
15.4.8.7. SWOT Analysis
15.4.9. Pfizer Inc.
15.4.10. PharmaCare Laboratories
15.4.11. Dr. Willmar Schwabe Group
15.4.12. SymbioPharm GmbH
16. Assumptions & Acronyms Used
17. Research Methodology
List of Table
Table 01: Global Probiotic Market Value (US$ Mn) Forecast by Region, 2014-2026
Table 02: Global Probiotic Market Value (US$ Mn) Forecast by Form, 2014-2026
Table 03: Global Probiotic Market Value (US$ Mn) Forecast by Packaging Type, 2014-2026
Table 04: Global Probiotic Market Value (US$ Mn) Forecast by Distribution Channel, 2014-2026
Table 05: North America Probiotic D.S. Market Value (US$ Mn) Forecast by Country, 2014-2026
Table 06: North America Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Country, 2014-2026
Table 07: North America Probiotic D.S. Market Value (US$ Mn) Forecast by Form, 2014-2026
Table 08: North America Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Form, 2014-2026
Table 09: North America Probiotic D.S. Market Value (US$ Mn) Forecast by Packaging Type, 2014-2026
Table 10: North America Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Packaging Type, 2014-2026
Table 11: North America Probiotic D.S. Market Value (US$ Mn) Forecast by Distribution Channel, 2014-2026
Table 12: North America Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Distribution Channel, 2014-2026
Table 13: Latin America Probiotic D.S. Market Value (US$ Mn) Forecast by Country, 2014-2026
Table 14: Latin America Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Country, 2014-2026
Table 15: Latin America Probiotic D.S. Market Value (US$ Mn) Forecast by Form, 2014-2026
Table 16: Latin America Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Form, 2014-2026
Table 17: Latin America Probiotic D.S. Market Value (US$ Mn) Forecast by Packaging Type, 2014-2026
Table 18: Latin America Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Packaging Type, 2014-2026
Table 19: Latin America Probiotic D.S. Market Value (US$ Mn) Forecast by Distribution Channel, 2014-2026
Table 20: Latin America Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Distribution Channel, 2014-2026
Table 21: Europe Probiotic D.S. Market Value (US$ Mn) Forecast by Country, 2014-2026
Table 22: Europe Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Country, 2014-2026
Table 23: Europe Probiotic D.S. Market Value (US$ Mn) Forecast by Form, 2014-2026
Table 24: Europe Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Form, 2014-2026
Table 25: Europe Probiotic D.S. Market Value (US$ Mn) Forecast by Packaging Type, 2014-2026
Table 26: Europe Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Packaging Type, 2014-2026
Table 27: Europe Probiotic D.S. Market Value (US$ Mn) Forecast by Distribution Channel, 2014-2026
Table 28: Europe Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Distribution Channel, 2014-2026
Table 29: APAC Probiotic D.S. Market Value (US$ Mn) Forecast by Country, 2014-2026
Table 30: APAC Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Country, 2014-2026
Table 31: APAC Probiotic D.S. Market Value (US$ Mn) Forecast by Form, 2014-2026
Table 32: APAC Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Form, 2014-2026
Table 33: APAC Probiotic D.S. Market Value (US$ Mn) Forecast by Packaging Type, 2014-2026
Table 34: APAC Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Packaging Type, 2014-2026
Table 35: APAC Probiotic D.S. Market Value (US$ Mn) Forecast by Distribution Channel, 2014-2026
Table 36: APAC Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Distribution Channel, 2014-2026
Table 37: MEA Probiotic D.S. Market Value (US$ Mn) Forecast by Country, 2014-2026
Table 38: MEA Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Country, 2014-2026
Table 39: MEA Probiotic D.S. Market Value (US$ Mn) Forecast by Form, 2014-2026
Table 40: MEA Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Form, 2014-2026
Table 41: MEA Probiotic D.S. Market Value (US$ Mn) Forecast by Packaging Type, 2014-2026
Table 42: MEA Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Packaging Type, 2014-2026
Table 43: MEA Probiotic D.S. Market Value (US$ Mn) Forecast by Distribution Channel, 2014-2026
Table 44: MEA Probiotic Pharmaceutical Market Value (US$ Mn) Forecast by Distribution Channel, 2014-2026
List of Figure
Figure 01: Global Probiotics Market Value (US$ Mn ), 2014-2026
Figure 02: Global Probiotic Market Value (US$ Mn) Analysis by Region, 2014-2026
Figure 03: Global Probiotic Market Value BPS Analysis, By Region, 2018 & 2026
Figure 04: Global Probiotic Market Value Y-o-Y Growth by Region, (2018-2026)
Figure 05: Global Probiotic Market Attractiveness by Region, 2018-2026
Figure 06: Global Probiotic Market Value (US$ Mn) Analysis by Form, 2014-2026
Figure 07: Global Probiotic Market Value BPS Analysis, By Form, 2018 & 2026
Figure 08: Global Probiotic Market Value Y-o-Y Growth by Form, (2018-2026)
Figure 09: Global Probiotic Market Attractiveness by Form, 2018-2026
Figure 10: Global Probiotic Market Value (US$ Mn) Analysis by Packaging Type, 2014-2026
Figure 11: Global Probiotic Market Value BPS Analysis, By Packaging Type, 2018 & 2026
Figure 12: Global Probiotic Market Value Y-o-Y Growth by Packaging Type, (2018-2026)
Figure 13: Global Probiotic Market Attractiveness by Packaging Type, 2018-2026
Figure 14: Global Probiotic Market Value (US$ Mn) Analysis by Distribution Channel, 2014-2026
Figure 15: Global Probiotic Market Value BPS Analysis, By Distribution Channel, 2018 & 2026
Figure 16: Global Probiotic Market Value Y-o-Y Growth by Distribution Channel, (2018-2026)
Figure 17: Global Probiotic Market Attractiveness by Packaging Type, 2018-2026
Figure 18: North America Probiotic D.S. Market Value (US$ Mn) Analysis by Country, 2014-2026
Figure 19: North America Probiotic D.S. Market Value BPS Analysis, By Country, 2018 & 2026
Figure 20: North America Probiotic D.S. Market Value Y-o-Y Growth by Country, (2018-2026)
Figure 21: North America Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Country, 2014-2026
Figure 22: North America Probiotic Pharmaceutical Market Value BPS Analysis, By Country, 2018 & 2026
Figure 23: North America Probiotic Pharmaceutical Market Value Y-o-Y Growth by Country, (2018-2026)
Figure 24: North America Probiotic D.S. Market Value (US$ Mn) Analysis by Form, 2014-2026
Figure 25: North America Probiotic D.S. Market Value BPS Analysis, By Form, 2018 & 2026
Figure 26: North America Probiotic D.S. Market Value Y-o-Y Growth by Form, (2018-2026)
Figure 27: North America Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Form, 2014-2026
Figure 28: North America Probiotic Pharmaceutical Market Value BPS Analysis, By Form, 2018 & 2026
Figure 29: North America Probiotic Pharmaceutical Market Value Y-o-Y Growth by Form, (2018-2026)
Figure 30: North America Probiotic D.S. Market Value (US$ Mn) Analysis by Packaging Type, 2014-2026
Figure 31: North America Probiotic D.S. Market Value BPS Analysis, By Packaging Type, 2018 & 2026
Figure 32: North America Probiotic D.S. Market Value Y-o-Y Growth by Packaging Type, (2018-2026)
Figure 33: North America Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Packaging Type, 2014-2026
Figure 34: North America Probiotic Pharmaceutical Market Value BPS Analysis, By Packaging Type, 2018 & 2026
Figure 35: North America Probiotic Pharmaceutical Market Value Y-o-Y Growth by Packaging Type, (2018-2026)
Figure 36: North America Probiotic D.S. Market Value (US$ Mn) Analysis by Distribution Channel, 2014-2026
Figure 37: North America Probiotic D.S. Market Value BPS Analysis, By Distribution Channel, 2018 & 2026
Figure 38: North America Probiotic D.S. Market Value Y-o-Y Growth by Distribution Channel, (2018-2026)
Figure 39: North America Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Distribution Channel, 2014-2026
Figure 40: North America Probiotic Pharmaceutical Market Value BPS Analysis, By Distribution Channel, 2018 & 2026
Figure 41: North America Probiotic Pharmaceutical Market Value Y-o-Y Growth by Distribution Channel, (2018-2026)
Figure 42: North America Probiotic D.S. Market Attractiveness by Country, 2018-2026
Figure 43: North America Probiotic D.S. Market Attractiveness by Form, 2018-2026
Figure 44: North America Probiotic D.S. Market Attractiveness by Packaging Type, 2018-2026
Figure 45: North America Probiotic D.S. Market Attractiveness by Distribution Channel, 2018-2026
Figure 46: North America Probiotic Pharmaceutical Market Attractiveness by Country, 2018-2026
Figure 47: North America Probiotic Pharmaceutical Market Attractiveness by Form, 2018-2026
Figure 48: North America Probiotic Pharmaceutical Market Attractiveness by Packaging Type, 2018-2026
Figure 49: North America Probiotic Pharmaceutical Market Attractiveness by Distribution Channel, 2018-2026
Figure 50: Latin America Probiotic D.S. Market Value (US$ Mn) Analysis by Country, 2014-2026
Figure 51: Latin America Probiotic D.S. Market Value BPS Analysis, By Country, 2018 & 2026
Figure 52: Latin America Probiotic D.S. Market Value Y-o-Y Growth by Country, (2018-2026)
Figure 53: Latin America Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Country, 2014-2026
Figure 54: Latin America Probiotic Pharmaceutical Market Value BPS Analysis, By Country, 2018 & 2026
Figure 55: Latin America Probiotic Pharmaceutical Market Value Y-o-Y Growth by Country, (2018-2026)
Figure 56: Latin America Probiotic D.S. Market Value (US$ Mn) Analysis by Form, 2014-2026
Figure 57: Latin America Probiotic D.S. Market Value BPS Analysis, By Form, 2018 & 2026
Figure 58: Latin America Probiotic D.S. Market Value Y-o-Y Growth by Form, (2018-2026)
Figure 59: Latin America Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Form, 2014-2026
Figure 60: Latin America Probiotic Pharmaceutical Market Value BPS Analysis, By Form, 2018 & 2026
Figure 61: Latin America Probiotic Pharmaceutical Market Value Y-o-Y Growth by Form, (2018-2026)
Figure 62: Latin America Probiotic D.S. Market Value (US$ Mn) Analysis by Packaging Type, 2014-2026
Figure 63: Latin America Probiotic D.S. Market Value BPS Analysis, By Packaging Type, 2018 & 2026
Figure 64: Latin America Probiotic D.S. Market Value Y-o-Y Growth by Packaging Type, (2018-2026)
Figure 65: Latin America Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Packaging Type, 2014-2026
Figure 66: Latin America Probiotic Pharmaceutical Market Value BPS Analysis, By Packaging Type, 2018 & 2026
Figure 67: Latin America Probiotic Pharmaceutical Market Value Y-o-Y Growth by Packaging Type, (2018-2026)
Figure 68: Latin America Probiotic D.S. Market Value (US$ Mn) Analysis by Distribution Channel, 2014-2026
Figure 69: Latin America Probiotic D.S. Market Value BPS Analysis, By Distribution Channel, 2018 & 2026
Figure 70: Latin America Probiotic D.S. Market Value Y-o-Y Growth by Distribution Channel, (2018-2026)
Figure 71: Latin America Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Distribution Channel, 2014-2026
Figure 72: Latin America Probiotic Pharmaceutical Market Value BPS Analysis, By Distribution Channel, 2018 & 2026
Figure 73: Latin America Probiotic Pharmaceutical Market Value Y-o-Y Growth by Distribution Channel, (2018-2026)
Figure 74: Latin America Probiotic D.S. Market Attractiveness by Country, 2018-2026
Figure 75: Latin America Probiotic D.S. Market Attractiveness by Form, 2018-2026
Figure 76: Latin America Probiotic D.S. Market Attractiveness by Packaging Type, 2018-2026
Figure 77: Latin America Probiotic D.S. Market Attractiveness by Distribution Channel, 2018-2026
Figure 78: Latin America Probiotic Pharmaceutical Market Attractiveness by Country, 2018-2026
Figure 79: Latin America Probiotic Pharmaceutical Market Attractiveness by Form, 2018-2026
Figure 80: Latin America Probiotic Pharmaceutical Market Attractiveness by Packaging Type, 2018-2026
Figure 81: Latin America Probiotic Pharmaceutical Market Attractiveness by Distribution Channel, 2018-2026
Figure 82: Europe Probiotic D.S. Market Value BPS Analysis, By Country, 2018 & 2026
Figure 83: Europe Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Country, 2014-2026
Figure 84: Europe Probiotic D.S. Market Value BPS Analysis, By Country, 2018 & 2026
Figure 85: Europe Probiotic Pharmaceutical Market Value BPS Analysis, By Country, 2018 & 2026
Figure 86: Europe Probiotic D.S. Market Value Y-o-Y Growth by Country, (2018-2026)
Figure 87: Europe Probiotic Pharmaceutical Market Value Y-o-Y Growth by Country, (2018-2026)
Figure 88: Europe Probiotic D.S. Market Value (US$ Mn) Analysis by Form, 2014-2026
Figure 89: Europe Probiotic D.S. Market Value BPS Analysis, By Form, 2018 & 2026
Figure 90: Europe Probiotic D.S. Market Value Y-o-Y Growth by Form, (2018-2026)
Figure 91: Europe Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Form, 2014-2026
Figure 92: Europe Probiotic Pharmaceutical Market Value BPS Analysis, By Form, 2018 & 2026
Figure 93: Europe Probiotic Pharmaceutical Market Value Y-o-Y Growth by Form, (2018-2026)
Figure 94: Europe Probiotic D.S. Market Value (US$ Mn) Analysis by Packaging Type, 2014-2026
Figure 95: Europe Probiotic D.S. Market Value BPS Analysis, By Packaging Type, 2018 & 2026
Figure 96: Europe Probiotic D.S. Market Value Y-o-Y Growth by Packaging Type, (2018-2026)
Figure 97: Europe Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Packaging Type, 2014-2026
Figure 98: Europe Probiotic Pharmaceutical Market Value BPS Analysis, By Packaging Type, 2018 & 2026
Figure 99: Europe Probiotic Pharmaceutical Market Value Y-o-Y Growth by Packaging Type, (2018-2026)
Figure 100: Europe Probiotic D.S. Market Value (US$ Mn) Analysis by Distribution Channel, 2014-2026
Figure 101: Europe Probiotic D.S. Market Value BPS Analysis, By Distribution Channel, 2018 & 2026
Figure 102: Europe Probiotic D.S. Market Value Y-o-Y Growth by Distribution Channel, (2018-2026)
Figure 103: Europe Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Distribution Channel, 2014-2026
Figure 104: Europe Probiotic Pharmaceutical Market Value BPS Analysis, By Distribution Channel, 2018 & 2026
Figure 105: Europe Probiotic Pharmaceutical Market Value Y-o-Y Growth by Distribution Channel, (2018-2026)
Figure 106: Europe Probiotic D.S. Market Attractiveness by Country, 2018-2026
Figure 107: Europe Probiotic D.S. Market Attractiveness by Form, 2018-2026
Figure 108: Europe Probiotic D.S. Market Attractiveness by Packaging Type, 2018-2026
Figure 109: Europe Probiotic D.S. Market Attractiveness by Distribution Channel, 2018-2026
Figure 110: Europe Probiotic Pharmaceutical Market Attractiveness by Country, 2018-2026
Figure 111: Europe Probiotic Pharmaceutical Market Attractiveness by Form, 2018-2026
Figure 112: Europe Probiotic Pharmaceutical Market Attractiveness by Packaging Type, 2018-2026
Figure 113: Europe Probiotic Pharmaceutical Market Attractiveness by Distribution Channel, 2018-2026
Figure 114: APAC Probiotic D.S. Market Value (US$ Mn) Analysis by Country, 2014-2026
Figure 115: APAC Probiotic D.S. Market Value BPS Analysis, By Country, 2018 & 2026
Figure 116: APAC Probiotic D.S. Market Value Y-o-Y Growth by Country, (2018-2026)
Figure 117: APAC Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Country, 2014-2026
Figure 118: APAC Probiotic Pharmaceutical Market Value BPS Analysis, By Country, 2018 & 2026
Figure 119: APAC Probiotic Pharmaceutical Market Value Y-o-Y Growth by Country, (2018-2026)
Figure 120: APAC Probiotic D.S. Market Value (US$ Mn) Analysis by Form, 2014-2026
Figure 121: APAC Probiotic D.S. Market Value BPS Analysis, By Form, 2018 & 2026
Figure 122: APAC Probiotic D.S. Market Value Y-o-Y Growth by Form, (2018-2026)
Figure 123: APAC Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Form, 2014-2026
Figure 124: APAC Probiotic Pharmaceutical Market Value BPS Analysis, By Form, 2018 & 2026
Figure 125: APAC Probiotic Pharmaceutical Market Value Y-o-Y Growth by Form, (2018-2026)
Figure 126: APAC Probiotic D.S. Market Value (US$ Mn) Analysis by Packaging Type, 2014-2026
Figure 127: APAC Probiotic D.S. Market Value BPS Analysis, By Packaging Type, 2018 & 2026
Figure 128: APAC Probiotic D.S. Market Value Y-o-Y Growth by Packaging Type, (2018-2026)
Figure 129: APAC Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Packaging Type, 2014-2026
Figure 130: APAC Probiotic Pharmaceutical Market Value BPS Analysis, By Packaging Type, 2018 & 2026
Figure 131: APAC Probiotic Pharmaceutical Market Value Y-o-Y Growth by Packaging Type, (2018-2026)
Figure 132: APAC Probiotic D.S. Market Value (US$ Mn) Analysis by Distribution Channel, 2014-2026
Figure 133: APAC Probiotic D.S. Market Value BPS Analysis, By Distribution Channel, 2018 & 2026
Figure 134: APAC Probiotic D.S. Market Value Y-o-Y Growth by Distribution Channel, (2018-2026)
Figure 135: APAC Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Distribution Channel, 2014-2026
Figure 136: APAC Probiotic Pharmaceutical Market Value BPS Analysis, By Distribution Channel, 2018 & 2026
Figure 137: APAC Probiotic Pharmaceutical Market Value Y-o-Y Growth by Distribution Channel, (2018-2026)
Figure 138: APAC Probiotic D.S. Market Attractiveness by Country, 2018-2026
Figure 139: APAC Probiotic D.S. Market Attractiveness by Form, 2018-2026
Figure 140: APAC Probiotic D.S. Market Attractiveness by Packaging Type, 2018-2026
Figure 141: APAC Probiotic D.S. Market Attractiveness by Distribution Channel, 2018-2026
Figure 142: APAC Probiotic Pharmaceutical Market Attractiveness by Country, 2018-2026
Figure 143: APAC Probiotic Pharmaceutical Market Attractiveness by Form, 2018-2026
Figure 144: APAC Probiotic Pharmaceutical Market Attractiveness by Packaging Type, 2018-2026
Figure 145: APAC Probiotic Pharmaceutical Market Attractiveness by Distribution Channel, 2018-2026
Figure 146: MEA Probiotic D.S. Market Value (US$ Mn) Analysis by Country, 2014-2026
Figure 147: MEA Probiotic D.S. Market Value BPS Analysis, By Country, 2018 & 2026
Figure 148: MEA Probiotic D.S. Market Value Y-o-Y Growth by Country, (2018-2026)
Figure 149: MEA Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Country, 2014-2026
Figure 150: MEA Probiotic Pharmaceutical Market Value BPS Analysis, By Country, 2018 & 2026
Figure 151: MEA Probiotic Pharmaceutical Market Value Y-o-Y Growth by Country, (2018-2026)
Figure 152: MEA Probiotic D.S. Market Value (US$ Mn) Analysis by Form, 2014-2026
Figure 153: MEA Probiotic D.S. Market Value BPS Analysis, By Form, 2018 & 2026
Figure 154: MEA Probiotic D.S. Market Value Y-o-Y Growth by Form, (2018-2026)
Figure 155: MEA Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Form, 2014-2026
Figure 156: MEA Probiotic Pharmaceutical Market Value BPS Analysis, By Form, 2018 & 2026
Figure 157: MEA Probiotic Pharmaceutical Market Value Y-o-Y Growth by Form, (2018-2026)
Figure 158: MEA Probiotic D.S. Market Value (US$ Mn) Analysis by Packaging Type, 2014-2026
Figure 159: MEA Probiotic D.S. Market Value BPS Analysis, By Packaging Type, 2018 & 2026
Figure 160: MEA Probiotic D.S. Market Value Y-o-Y Growth by Packaging Type, (2018-2026)
Figure 161: MEA Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Packaging Type, 2014-2026
Figure 162: MEA Probiotic Pharmaceutical Market Value BPS Analysis, By Packaging Type, 2018 & 2026
Figure 163: MEA Probiotic Pharmaceutical Market Value Y-o-Y Growth by Packaging Type, (2018-2026)
Figure 164: MEA Probiotic D.S. Market Value (US$ Mn) Analysis by Distribution Channel, 2014-2026
Figure 165: MEA Probiotic D.S. Market Value BPS Analysis, By Distribution Channel, 2018 & 2026
Figure 166: MEA Probiotic D.S. Market Value Y-o-Y Growth by Distribution Channel, (2018-2026)
Figure 167: MEA Probiotic Pharmaceutical Market Value (US$ Mn) Analysis by Distribution Channel, 2014-2026
Figure 168: MEA Probiotic Pharmaceutical Market Value BPS Analysis, By Distribution Channel, 2018 & 2026
Figure 169: MEA Probiotic Pharmaceutical Market Value Y-o-Y Growth by Distribution Channel, (2018-2026)
Figure 170: MEA Probiotic D.S. Market Attractiveness by Country, 2018-2026
Figure 171: MEA Probiotic D.S. Market Attractiveness by Form, 2018-2026
Figure 172: MEA Probiotic D.S. Market Attractiveness by Packaging Type, 2018-2026
Figure 173: MEA Probiotic D.S. Market Attractiveness by Distribution Channel, 2018-2026
Figure 174: MEA Probiotic Pharmaceutical Market Attractiveness by Country, 2018-2026
Figure 175: MEA Probiotic Pharmaceutical Market Attractiveness by Form, 2018-2026
Figure 176: MEA Probiotic Pharmaceutical Market Attractiveness by Packaging Type, 2018-2026
Figure 177: MEA Probiotic Pharmaceutical Market Attractiveness by Distribution Channel, 2018-2026